Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Eric Roeland

    TitleAssistant Clinical Professor
    SchoolUniversity of California, San Diego
    Address3855 Health Sciences Drive #0987
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California San DiegoHematology/Oncology Fellowship2012Medicine
      San Diego Hospice & The Institute for Palliative MedicineHospice & Palliative Medicine Fellowship2009
      University of California San DiegoInternship & Residency2008Medicine
      University of Colorado Health Sciences CenterDoctor of Medicine2005School of Medicine
      Northwestern UniversityBachelor of Arts2000Weinberg College of Arts & Sciences
      Collapse Awards and Honors
      San Diego County Medical Society2015San Diego’s 2015 Top Doctors Hospice & Palliative Medicine
      American Academy of Hospice & Palliative Medicine2015Inspirational Leader Under 40 Award
      Massachusetts General Hospital2015Workshop on Methods in Supportive Oncology
      American Society of Clinical Oncology/American Association Cancer Research2015Vail Workshop Methods in Clinical Cancer Research
      American Academy of Hospice & Palliative Medicine2015Fellow of the Academy
      American Academy of Hospice & Palliative Medicine2014Kathleen Foley Palliative Care Research Scholars Award
      University of California San Diego2013National Center of Leadership in Academic Medicine
      American Society of Clinical Oncology2011Travel Scholar

      Collapse Overview 
      Collapse Overview
      Research Interests
      As an oncologist and palliative medicine physician, Dr. Roeland is committed to finding more effective solutions for improving the quality of care for cancer patients with advanced disease. He intimately understands the importance of integrating cancer treatment with optimal symptom control. He also has the unique advantage of having training in both oncology and palliative medicine. His current research is primarily focused on symptom intervention clinical trials across the entire spectrum of cancer. Ultimately, he wants to promote a new standard for cancer care – simultaneous integrated oncology and palliation.

      7/12-Present Principal Investigator, UCSD Moores Cancer Center, Supportive Oncology Trials

      A Randomized Phase II Placebo-Controlled Study of LY2495655 (Myostatin Inhibitor) in Patients with Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy

      Merck V212-011: A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

      Single Center, Randomized, Prospective Study Evaluating Advance Care Planning and Documentation Implementing The 3 Questions™ in Initiating Advance Care Planning Between Patients and Their Chosen Healthcare Proxy vs. Traditional Advance Directives in an Outpatient Academic Palliative Medicine Clinic

      Education and Training
      Bachelor of Arts - Spanish Language, Northwestern University - 05/00
      MD - University of Colorado Health Sciences Center - 05/05
      Internal Medicine Internship & Residency - University of California San Diego - 06/08
      Hospice & Palliative Medicine Fellowship - San Diego Hospice & The Institute for Palliative Medicine - 06/09
      Hematology & Oncology Fellowship - University of California San Diego - 06/12

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse Featured Videos
      Collapse Featured Presentations
      Collapse Faculty Mentoring
      Collapse Twitter
      Collapse In The News

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, Boero IJ, Roeland E, Yeung HN, Murphy JD. Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer. J Oncol Pract. 2017 Sep; 13(9):e760-e769. PMID: 28829693.
        View in: PubMed
      2. Roeland E. Managing Malignant Bowel Obstruction: Moving Beyond Drip and Suck. J Oncol Pract. 2017 Jul; 13(7):437-438. PMID: 28697321.
        View in: PubMed
      3. Wang WS, Ma JD, Nelson SH, Revta C, Buckholz GT, Mulroney CM, Roeland E. Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation. J Oncol Pract. 2017 Sep; 13(9):e721-e728. PMID: 28644706.
        View in: PubMed
      4. LeBlanc TW, Roeland E, El-Jawahri A. Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve? Curr Hematol Malig Rep. 2017 Jun 21. PMID: 28639084.
        View in: PubMed
      5. Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol. 2017 Jun 01; 28(6):1260-1267. PMID: 28398530.
        View in: PubMed
      6. Martin EJ, Roeland E, Sharp MB, Revta C, Murphy JD, Fero KE, Yeung HN. Patient-Controlled Analgesia for Cancer-Related Pain: Clinical Predictors of Patient Outcomes. J Natl Compr Canc Netw. 2017 May; 15(5):595-600. PMID: 28476739.
        View in: PubMed
      7. Vadhan-Raj S, Abonour R, Goldman JW, Smith DA, Slapak CA, Ilaria RL, Tiu RV, Wang X, Callies S, Cox J, Tuttle JL, Lau YK, Roeland E. A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. J Hematol Oncol. 2017 Mar 21; 10(1):73. PMID: 28327200.
        View in: PubMed
      8. Roeland E. Tailoring Palliative Care to the Changing Needs of People Facing Cancer. J Clin Oncol. 2017 Mar 10; 35(8):813-815. PMID: 28113031.
        View in: PubMed
      9. Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland E. Cancer Cachexia: Beyond Weight Loss. J Oncol Pract. 2016 Nov; 12(11):1163-1171. PMID: 27858548.
        View in: PubMed
      10. Roeland E, Ma JD, Nelson SH, Seibert T, Heavey S, Revta C, Gallivan A, Baracos VE. Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials. Support Care Cancer. 2017 Feb; 25(2):365-369. PMID: 27628947.
        View in: PubMed
      11. Kronenberg DG, Hagmann CH, Ma JD, Revta C, Armstrong J, Roeland E. The Default Dilemma: Code Status Regardless of Medical Context. J Palliat Med. 2016 Nov; 19(11):1134. PMID: 27500355.
        View in: PubMed
      12. Roeland E, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. J Natl Compr Canc Netw. 2016 Apr; 14(4):439-45. PMID: 27059192.
        View in: PubMed
      13. Roeland E, LeBlanc TW. Palliative chemotherapy: oxymoron or misunderstanding? BMC Palliat Care. 2016 Mar 21; 15:33. PMID: 27000049; PMCID: PMC4802642.
      14. Ma JD, Benn M, Nelson SH, Campillo A, Heavey SF, Cramer A, Revta C, Thornberry K, Roeland E. Exploring the Definition of an Informed Health Care Proxy. J Palliat Med. 2016 Mar; 19(3):250-1. PMID: 26836962.
        View in: PubMed
      15. Gramling R, Stanek S, Ladwig S, Gajary-Coots E, Cimino J, Anderson W, Norton SA, Aslakson RA, Ast K, Elk R, Garner KK, Gramling R, Grudzen C, Kamal AH, Lamba S, LeBlanc TW, Rhodes RL, Roeland E, Schulman-Green D, Unroe KT. Feeling Heard and Understood: A Patient-Reported Quality Measure for the Inpatient Palliative Care Setting. J Pain Symptom Manage. 2016 Feb; 51(2):150-4. PMID: 26596879.
        View in: PubMed
      16. Roeland E, Aapro MS, Schwartzberg LS. Advances in the Management of Chemotherapy-Induced Nausea and Vomiting: New Data From Recent and Ongoing Trials. Clin Adv Hematol Oncol. 2015 Oct; 13(10 Suppl 10):1-14. PMID: 26859507.
        View in: PubMed
      17. Montross-Thomas LP, Irwin SA, Meier EA, Gallegos JV, Golshan S, Roeland E, McNeal H, Munson D, Rodseth L. Enhancing legacy in palliative care: study protocol for a randomized controlled trial of Dignity Therapy focused on positive outcomes. BMC Palliat Care. 2015 Sep 21; 14:44. PMID: 26391775; PMCID: PMC4578680.
      18. Chang A, Roeland E, Atayee RS, Revta C, Ma JD. Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care. J Pain Palliat Care Pharmacother. 2015 Sep; 29(3):247-60. PMID: 26368648.
        View in: PubMed
      19. Lin KJ, Ching A, Edmonds KP, Roeland E, Revta C, Ma JD, Atayee RS. Variable Patterns of Continuous Morphine Infusions at End of Life. J Palliat Med. 2015 Sep; 18(9):786-9. PMID: 26107143; PMCID: PMC4553381.
      20. Langley-DeGroot M, Ma JD, Hirst J, Roeland E. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature. J Pain Palliat Care Pharmacother. 2015 Jun; 29(2):148-52. PMID: 26095486.
        View in: PubMed
      21. Bruggeman AR, Heavey SF, Ma JD, Revta C, Roeland E. Lack of documentation of evidence-based prognostication in cancer patients by inpatient palliative care consultants. J Palliat Med. 2015 Apr; 18(4):382-5. PMID: 25608220.
        View in: PubMed
      22. Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer. 2015 Aug; 23(8):2231-44. PMID: 25564221; PMCID: PMC4996115.
      23. Roeland E, Ku G. Spanning the canyon between stem cell transplantation and palliative care. Hematology Am Soc Hematol Educ Program. 2015; 2015:484-9. PMID: 26637762.
        View in: PubMed
      24. Wong J, Xu B, Yeung HN, Roeland E, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):224-30. PMID: 25195994; PMCID: PMC4187217.
      25. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland E, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. PMID: 25145504.
        View in: PubMed
      26. Amin P, Roeland E, Atayee R. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain. J Pain Palliat Care Pharmacother. 2014 Sep; 28(3):233-42. PMID: 25102039.
        View in: PubMed
      27. Heavey SF, Roeland E, Tipps AM, Datnow B, Sicklick JK. Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol. 2014 Aug; 5(4):E58-64. PMID: 25083307; PMCID: PMC4110491.
      28. Yeung HN, Mitchell WM, Roeland E, Xu B, Mell LK, Le QT, Murphy JD. Palliative radiation before hospice: the long and the short of it. J Pain Symptom Manage. 2014 Dec; 48(6):1070-9. PMID: 24819083.
        View in: PubMed
      29. Ma JD, Heavey SF, Revta C, Roeland E. Novel investigational biologics for the treatment of cancer cachexia. Expert Opin Biol Ther. 2014 Aug; 14(8):1113-20. PMID: 24707881.
        View in: PubMed
      30. Roeland E, Cain J, Onderdonk C, Kerr K, Mitchell W, Thornberry K. When open-ended questions don't work: the role of palliative paternalism in difficult medical decisions. J Palliat Med. 2014 Apr; 17(4):415-20. PMID: 24588626.
        View in: PubMed
      31. Wong-Sefdan I, Ale-Ali A, DeMoor PA, Martinez S, Curtin P, Lane T, Roeland E. Implementing inpatient, evidence-based, antihistamine-transfusion premedication guidelines at a single academic US hospital. J Community Support Oncol. 2014 Feb; 12(2):56-64. PMID: 24971406.
        View in: PubMed
      32. Ma JD, Horton JM, Hwang M, Atayee RS, Roeland E. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients. J Pain Palliat Care Pharmacother. 2014 Mar; 28(1):4-9. PMID: 24417217.
        View in: PubMed
      33. Hwang M, Pirrello R, Pu M, Messer K, Roeland E. Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital. Support Care Cancer. 2013 Oct; 21(10):2817-24. PMID: 23732621.
        View in: PubMed
      34. Roeland E, Loprinzi C, Moynihan TJ, Smith TJ, Temel J. In chemotherapy for lung cancer, sometimes less is more. J Natl Compr Canc Netw. 2013 Mar 01; 11(3):232-5. PMID: 23486449.
        View in: PubMed
      35. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 2: psychosocial concerns. J Support Oncol. 2010 Jul-Aug; 8(4):179-83. PMID: 20822037.
        View in: PubMed
      36. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms. J Support Oncol. 2010 May-Jun; 8(3):100-16. PMID: 20552923.
        View in: PubMed
      37. Roeland E, von Gunten CF. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009 Jul; 11(4):298-303. PMID: 19508835.
        View in: PubMed
      38. Roeland E. Darkness is no more. J Palliat Med. 2009 Apr; 12(4):389-90. PMID: 19327081.
        View in: PubMed
      Eric's Networks
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Similar People
      People who share similar concepts with this person.
      Physical Neighbors
      People whose addresses are nearby this person.